J&J’s Heart Deal Pumps Up Post-Breakup Prospects
November 02, 2022 at 06:25 AM EDT
Johnson & Johnson is betting that devices designed to keep patients’ hearts pumping will do something similar to its revenue growth.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|